Schrodinger (SDGR) Stock Price, News & Analysis

Company Overview

Schrödinger, Inc. develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company’s tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations.

Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates. Its research has included programs in areas such as oncology and immunology, and its collaborations provide partners access to the company’s computational platform and scientific expertise.

Founded in 1990, Schrödinger serves customers and partners internationally. The company is headquartered in New York City and is led by co-founder and Chief Executive Officer Ramy Farid.

Key Stats

• Today's Range: $28.17 to $30.85
• 50-Day Range: $18.80 to $33.39
• 52-Week Range: $10.94 to $34.00
• Volume: 1.28 million shs
• Average Volume: 1.75 million shs
• Market Capitalization: $2.18 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $26.67
• Consensus Rating: Hold

Schrodinger Stock Analysis - MarketRank™

Schrodinger scored higher than 38% of companies evaluated by MarketBeat, and ranked 709th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Hold

Consensus Rating

Schrodinger has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 4 buy ratings, 3 hold ratings, and 1 sell rating.

Downside Risk

Schrodinger has a consensus price target of $26.67, representing about 9.7% downside from its current price of $29.53.

Amount of Analyst Coverage

Schrodinger has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Schrodinger are expected to grow in the coming year, from ($1.39) to ($1.11) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Schrodinger is -37.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Schrodinger is -37.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Schrodinger has a P/B Ratio of 7.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

14.69% of the float of Schrodinger has been sold short.

Short Interest Ratio / Days to Cover

Schrodinger has a short interest ratio ("days to cover") of 5.82.

Change versus previous month

Short interest in Schrodinger has recently decreased by 6.27%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Schrodinger does not currently pay a dividend.

Dividend Growth

Schrodinger does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.64

News Sentiment

Schrodinger has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Schrodinger this week, compared to 3 articles on an average week.

Search Interest

Only 8 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

MarketBeat Follows

7 people have added Schrodinger to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Schrodinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,781,833.00 in company stock.

Percentage Held by Insiders

10.10% of the stock of Schrodinger is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/04/2026
• Today: 11/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:SDGR
• CIK: 1490978
• Web: www.schrodinger.com
• Phone: 212-295-5800
• Fax: N/A
• Employees: 850
• Year Founded: 1990

Price Target and Rating

• Average Price Target for Schrodinger: $26.67
• High Price Target: $36.00
• Low Price Target: $17.00
• Potential Upside/Downside: -9.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.38
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.79)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$103.26 million
• Net Margins: -22.02%
• Pretax Margin: -21.12%
• Return on Equity: -18.12%
• Return on Assets: -9.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.75
• Quick Ratio: 2.75

Sales & Book Value

• Annual Sales: $255.87 million
• Price / Sales: 8.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.09 per share
• Price / Book: 7.22

Miscellaneous

• Outstanding Shares: 73,820,000
• Free Float: 66,369,000
• Market Cap: $2.18 billion
• Optionable: Optionable
• Beta: 1.69